Does tranexamic acid reduce blood transfusion cost for primary total hip arthroplasty? A case-control study

Journal of Arthroplasty

Volumn 30, Issue 2, 2015, Pages 192-195

  Harris, Ryan N ^a   Moskal, Joseph T ^a   Capps, Susan G ^b  

^a VIRGINIA TECH CARILION SCHOOL OF MEDICINE   (United States)

^b BENSOL Biological Engineering Solutions   (United States)

Author keywords

Cost; Hip arthroplasty; Tranexamic acid; Transfusion

Indexed keywords

TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT;

ADULT; ARTICLE; BLOOD TRANSFUSION; CASE CONTROL STUDY; COHORT ANALYSIS; COST BENEFIT ANALYSIS; COST CONTROL; FEMALE; HEALTH CARE COST; HIP ARTHROPLASTY; HOSPITAL COST; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NURSING; NURSING PROTOCOL; PRIMARY TOTAL HIP ARTHROPLASTY; TERTIARY CARE CENTER; TOTAL HIP PROSTHESIS; AGED; ECONOMICS; MIDDLE AGED; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTIFIBRINOLYTIC AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; BLOOD TRANSFUSION; CASE-CONTROL STUDIES; FEMALE; HOSPITAL COSTS; HUMANS; MALE; MIDDLE AGED; TRANEXAMIC ACID; YOUNG ADULT;

EID: 84925217517     PISSN: 08835403     EISSN: 15328406     Source Type: Journal    
DOI: 10.1016/j.arth.2014.08.020     Document Type: Article

References (12)

1. Alshryda S., Mason J., Sarda P., et al. Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total hip replacement. A randomized controlled trial (TRANX-H). J Bone Joint Surg Am 2013, 95(21):1969.
2. Gilbody J., Dhotar H.S., Perruccio A.V., et al. Topical tranexamic acid reduces transfusion rates in total hip and knee arthroplasty. J Arthroplasty 2013, 10.1016/j.arth.2013.09.005.
3. Singh J., Ballal M.S., Mitchell P., et al. Effects of tranexamic acid on blood loss during total hip arthroplasty. J Orthop Surg 2010, 18(3):282.
4. Wind T.C., Barfield W.R., Moskal J.T. The effect of tranexamic acid on transfusion rate in primary total hip arthroplasty. J Arthroplasty 2013, 28(7):1080.
5. Browne J.A., Adib F., Brown T.E., et al. Transfusion rates are increasing following total hip arthroplasty: risk factors and outcomes. J Arthroplasty 2013, 28(8 Suppl):34.
6. Gillette B.P., Maradit Kremers H., Duncan C.M., et al. Economic impact of tranexamic acid in healthy patients undergoing primary total hip and knee arthroplasty. J Arthroplasty 2013, 28(8 Suppl):137.
7. Niskanen R.O., Korkala O.L. Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis. Acta Orthop 2005, 76(6):829.
8. Johansson T., Pettersson L.G., Lisander B. Tranexamic acid in total hip arthroplasty saves blood and money: a randomized, double-blind study in 100 patients. Acta Orthop 2005, 76(3):314.
9. Alshryda S., Mason J.M., Sarda P., et al. The effect of tranexamic acid on artificial joint materials: a biomechanical study (the bioTRANX study). J Orthop Traumatol 2014, [Epub ahead of print].
10. Shander A., Hofmann A., Ozawa S., et al. Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion 2010, 50(4):753.
11. Medicare general information, eligibility, and entitlement Chapter 3 - deductibles, coinsurance amounts, and payment limitations (rev. 82, 11-15-13) http://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/downloads/ge101c03.pdf.
12. Gluck F. Hospitals look to limit transfusions. USA Today 2013.